Sichuan Hexie Shuangma Co.,Ltd. (000935.SZ) announced that its controlling subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. ("Hubei Jianxiang") underwent an on-site inspection by the State Drug Inspection Authority under the Russian Ministry of Industry and Trade from July 30 to August 1, 2025. Recently, the company received the "Eurasian Economic Union Good Manufacturing Practice Compliance Certificate" ("GMP Certificate") issued by the Russian Ministry of Industry and Trade, confirming that Hubei Jianxiang successfully passed the inspection.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments